Literature DB >> 33879097

Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study.

Chonachan Petcharat1, Varalak Srinonprasert2, Praveena Chiowchanwisawakit3.   

Abstract

OBJECTIVE: To investigate the prevalence of and factors associated with metabolic syndrome (MetS) in patients with psoriatic arthritis (PsA) or ankylosing spondylitis (AS).
METHODS: This cross-sectional study included PsA or AS patients who attended Siriraj Hospital (Bangkok, Thailand) during March 2014 to October 2017. The Harmonized MetS definition was used to diagnose MetS. Demographic, clinical, and spinal radiographic data were collected. Logistic regression was used to identify factors associated with MetS.
RESULTS: Among 319 patients, 153 had AS and 166 had PsA. MetS was present in 43% of PsA and 19% of AS (p < 0.001). Multiple regression analysis identified body mass index (BMI) > 23 (odds ratio [OR]: 3.7), female gender (OR range: 3.8-3.9), and the number of syndesmophytes or ankylosis [SynAnk] (OR: 1.1) were associated with MetS among PsA patients. For AS patients, BMI > 23 (OR: 9.1) and age > 40 (OR: 4.3) were associated with MetS. Disease activity index was not associated with MetS.
CONCLUSIONS: MetS was significantly more prevalent in PsA than in AS. Structural change of the spine was associated with MetS in PsA. PsA patients with being female, BMI > 23 or evidence of spinal change should be informed to screen for MetS. AS patients with age > 40 or BMI > 23 should be informed to screen for MetS.

Entities:  

Keywords:  Ankylosing spondylitis; Cross-sectional study; Factors; Metabolic syndrome; Prevalence; Psoriatic arthritis

Year:  2021        PMID: 33879097     DOI: 10.1186/s12891-021-04222-8

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  38 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 2.  Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.

Authors:  Anna Jamnitski; Deborah Symmons; Mike J L Peters; Naveed Sattar; Iain McInnes; Iain McIinnes; Michael T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

Review 3.  Cardiovascular disease in inflammatory rheumatic diseases.

Authors:  Santos Castañeda; Michael T Nurmohamed; Miguel A González-Gay
Journal:  Best Pract Res Clin Rheumatol       Date:  2016-11-09       Impact factor: 4.098

4.  Cardiovascular events in ankylosing spondylitis: an updated meta-analysis.

Authors:  Sylvain Mathieu; Bruno Pereira; Martin Soubrier
Journal:  Semin Arthritis Rheum       Date:  2014-10-18       Impact factor: 5.532

5.  Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.

Authors:  Carlos Gonzalez-Juanatey; Javier Llorca; Jose A Miranda-Filloy; Encarnacion Amigo-Diaz; Ana Testa; Carlos Garcia-Porrua; Javier Martin; Miguel A Gonzalez-Gay
Journal:  Arthritis Rheum       Date:  2007-03-15

Review 6.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Authors:  R Agca; S C Heslinga; S Rollefstad; M Heslinga; I B McInnes; M J L Peters; T K Kvien; M Dougados; H Radner; F Atzeni; J Primdahl; A Södergren; S Wallberg Jonsson; J van Rompay; C Zabalan; T R Pedersen; L Jacobsson; K de Vlam; M A Gonzalez-Gay; A G Semb; G D Kitas; Y M Smulders; Z Szekanecz; N Sattar; D P M Symmons; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2016-10-03       Impact factor: 19.103

7.  Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study.

Authors:  Nisha Nigil Haroon; J Michael Paterson; Ping Li; Robert D Inman; Nigil Haroon
Journal:  Ann Intern Med       Date:  2015-09-15       Impact factor: 25.391

8.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

Review 9.  Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.

Authors:  C Horreau; C Pouplard; E Brenaut; T Barnetche; L Misery; B Cribier; D Jullien; S Aractingi; F Aubin; P Joly; M Le Maître; J-P Ortonne; C Paul; M-A Richard
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-08       Impact factor: 6.166

10.  Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis.

Authors:  Yaping Yuan; Jiajia Yang; Xu Zhang; Renfang Han; Mengya Chen; Xingxing Hu; Yubo Ma; Meng Wu; Mengmeng Wang; Shengqian Xu; Faming Pan
Journal:  J Atheroscler Thromb       Date:  2018-08-08       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.